X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pharmacokinetics (15) 15
humans (14) 14
index medicus (14) 14
male (14) 14
adult (13) 13
female (13) 13
middle aged (11) 11
pharmacology & pharmacy (11) 11
young adult (7) 7
drug interactions (6) 6
adolescent (5) 5
cross-over studies (5) 5
pharmacodynamics (5) 5
pharmacology (5) 5
area under curve (4) 4
bioavailability (4) 4
dosage and administration (4) 4
factor-xa inhibitor (4) 4
healthy volunteers (4) 4
rivaroxaban (4) 4
tolerability (4) 4
analysis (3) 3
anticoagulants - pharmacokinetics (3) 3
drug administration schedule (3) 3
efficacy (3) 3
factor xa inhibitors - pharmacokinetics (3) 3
prothrombin time (3) 3
safety (3) 3
therapeutic equivalency (3) 3
thiophenes - adverse effects (3) 3
thiophenes - pharmacokinetics (3) 3
usage (3) 3
absorption (2) 2
analgesics, opioid - administration & dosage (2) 2
analgesics, opioid - pharmacokinetics (2) 2
anticoagulants - administration & dosage (2) 2
anticoagulants - adverse effects (2) 2
antipsychotic agents - blood (2) 2
articles (2) 2
bay-59-7939 (2) 2
belgium (2) 2
canagliflozin (2) 2
children (2) 2
confidence intervals (2) 2
delayed-action preparations (2) 2
double-blind (2) 2
double-blind method (2) 2
drug dosages (2) 2
drug-drug interactions (2) 2
factor xa inhibitors - administration & dosage (2) 2
factor xa inhibitors - adverse effects (2) 2
food-drug interactions (2) 2
guidelines (2) 2
half-life (2) 2
hydromorphone - administration & dosage (2) 2
hydromorphone - adverse effects (2) 2
hydromorphone - pharmacokinetics (2) 2
international normalized ratio (2) 2
metabolism (2) 2
morpholines - adverse effects (2) 2
morpholines - pharmacokinetics (2) 2
morpholines - pharmacology (2) 2
original manuscript (2) 2
oros hydromorphone (2) 2
p-glycoprotein (2) 2
pain (2) 2
research (2) 2
risperidone (2) 2
rivaroxaban - administration & dosage (2) 2
rivaroxaban - pharmacokinetics (2) 2
schizophrenia (2) 2
sodium-glucose transporter 2 - antagonists & inhibitors (2) 2
task-force (2) 2
thiophenes - pharmacology (2) 2
urology & nephrology (2) 2
volunteers (2) 2
warfarin (2) 2
warfarin - administration & dosage (2) 2
warfarin - pharmacokinetics (2) 2
acute pain (1) 1
administration, cutaneous (1) 1
administration, intravenous (1) 1
administration, oral (1) 1
adrenergic beta blockers (1) 1
adults (1) 1
adverse events (1) 1
age groups (1) 1
aged (1) 1
analgesics (1) 1
analgesics, opioid - adverse effects (1) 1
antibodies - blood (1) 1
anticoagulant (1) 1
anticoagulant ? factor xa inhibitor ? rivaroxaban ? end-stage renal disease ? hemodialysis ? pharmacokinetics ? pharmacodynamics (1) 1
anticoagulants - blood (1) 1
anticoagulants - pharmacology (1) 1
antimanic agents - administration & dosage (1) 1
antimanic agents - blood (1) 1
antipsychotic agents - administration & dosage (1) 1
antipsychotic agents - adverse effects (1) 1
antipsychotic drug monitoring (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Clinical Pharmacology, ISSN 0091-2700, 12/2014, Volume 54, Issue 12, pp. 1407 - 1420
Journal Article
Journal Article
Journal of Opioid Management, ISSN 1551-7489, 03/2011, Volume 7, Issue 2, pp. 99 - 107
Fentanyl is a potent synthetic opioid used for the management of chronic pain. A newer transdermal matrix system was developed and compared with a reservoir... 
Fentanyl | Drug delivery | Matrix | Transdermal | Pharmacokinetics | Fentanyl - administration & dosage | Fentanyl - adverse effects | Humans | Middle Aged | Fentanyl - pharmacokinetics | Male | Administration, Cutaneous | Cross-Over Studies | Analgesics, Opioid - administration & dosage | Adolescent | Adult | Female | Therapeutic Equivalency
Journal Article
JOURNAL OF PAIN RESEARCH, ISSN 1178-7090, 2019, Volume 12, pp. 1925 - 1936
Background: This is the first clinical trial in the global pediatric clinical development program for the use of the analgesic tapentadol in children and... 
IMMEDIATE-RELEASE | PLACEBO | EFFICACY | acute pain | PHASE-III | VALIDATION | mu-opioid | CLINICAL NEUROLOGY | OXYCODONE IR | children | TOLERABILITY | efficacy and safety | pharmacokinetics | DOUBLE-BLIND | tapentadol | SCALE | Pediatrics | Pain | Narcotics | Analgesics | Surgery | Population | FDA approval | Drug dosages | Age groups | µ-opioid
Journal Article
Clinical Pharmacology in Drug Development, ISSN 2160-763X, 01/2019, Volume 8, Issue 1, pp. 95 - 106
We evaluated the effects of therapeutic and supratherapeutic doses of tramadol hydrochloride on the corrected QT (QTc) interval in healthy adults (aged... 
QT/QTc prolongation | electrocardiogram | tramadol hydrochloride | pharmacodynamics | cardiac repolarization | pharmacokinetics | moxifloxacin | GENETIC-POLYMORPHISM | EFFICACY | SAFETY | PROLONGATION | EXTENDED-RELEASE FORMULATIONS | IMPACT | METABOLISM | CYP2D6 | PHARMACOLOGY | PHARMACOLOGY & PHARMACY | Original Manuscript | QTc prolongation
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 06/2015, Volume 79, Issue 6, pp. 907 - 917
Journal Article
Journal Article
Journal Article
Journal Article
Clinical Pharmacology in Drug Development, ISSN 2160-763X, 07/2015, Volume 4, Issue 4, pp. 279 - 286
Journal Article
American Journal of Nephrology, ISSN 0250-8095, 09/2016, Volume 44, Issue 2, pp. 169 - 169
Journal Article